PDRN CareSenescent Cells
Dr. Sarah Chen
PhD, Molecular Biology
Senescent cells are cells that have undergone a stable, irreversible exit from the cell cycle in response to various stress signals while remaining metabolically active [1].
Definition
Senescent cells are cells that have undergone a stable, irreversible exit from the cell cycle in response to various stress signals while remaining metabolically active [1]. Unlike quiescent cells, which can re-enter the cell cycle when stimulated, senescent cells are permanently growth-arrested. Despite their inability to divide, senescent cells are far from inert β they adopt a highly active secretory program known as the senescence-associated secretory phenotype (SASP) that profoundly alters the tissue microenvironment [1][3]. In skin, the accumulation of senescent cells β particularly senescent fibroblasts β is a major driver of age-related dermal deterioration [2].
Triggers of Cellular Senescence
Replicative Senescence
The best-characterized trigger is telomere shortening below a critical threshold, which activates the DNA damage response (DDR) and engages the p53/p21 tumor suppressor pathway [1]. This form of senescence limits the total number of divisions a cell can undergo and is sometimes called the Hayflick limit.
Stress-Induced Premature Senescence
Cells can enter senescence prematurely β well before reaching their replicative limit β in response to acute stressors [1][2]:
- Oxidative stress β Reactive oxygen species cause DNA damage, particularly at telomeric regions, triggering DDR activation
- UV radiation β Induces both direct DNA damage and oxidative stress in skin cells
- Oncogene activation β Aberrant growth signals trigger senescence as a tumor-suppressive mechanism
- Mitochondrial dysfunction β Impaired electron transport increases intracellular ROS production
In sun-exposed skin, stress-induced premature senescence is often more significant than replicative senescence, explaining why photoaged areas accumulate senescent cells far more rapidly than sun-protected sites [2].
The Senescence-Associated Secretory Phenotype (SASP)
The SASP is the most damaging aspect of cellular senescence for tissue integrity [3]. Senescent cells secrete a complex mixture of:
- Pro-inflammatory cytokines β IL-1alpha, IL-1beta, IL-6, and IL-8, which sustain chronic low-grade inflammation (inflammaging) [3]
- Matrix metalloproteinases β MMP-1, MMP-3, and MMP-9, which degrade collagen, elastin, and other extracellular matrix components [3]
- Growth factors β Including VEGF and certain chemokines that can alter neighboring cell behavior [3]
- Reactive oxygen species β Further propagating oxidative stress to adjacent cells [1][3]
A single senescent fibroblast, through its SASP, can induce senescence in neighboring healthy fibroblasts β a bystander effect that creates expanding zones of tissue dysfunction [3]. This paracrine senescence amplification is a key mechanism in age-related dermal thinning and elasticity loss [2].
Senescent Cells in Skin Aging
Aged human skin shows a significant increase in senescent fibroblast density, particularly in the papillary dermis [2]. These senescent fibroblasts exhibit:
- Reduced collagen production β Type I and type III procollagen synthesis drops dramatically [2]
- Elevated MMP secretion β Continuous matrix degradation even without UV exposure [2][3]
- Flattened, enlarged morphology β Senescent fibroblasts spread out and lose the elongated spindle shape of functional cells [2]
- Beta-galactosidase activity β A commonly used biomarker for detecting senescent cells in tissue samples [1]
The net effect is a progressively deteriorating dermal environment: less collagen production, more collagen destruction, chronic inflammation, and impaired tissue regeneration [2].
How PDRN Modulates Senescence
PDRN does not eliminate existing senescent cells (it is not a senolytic), but it modulates the pathways that both drive cells toward senescence and amplify senescence-related damage [4][5]:
Reducing Oxidative Senescence Triggers
PDRN's A2A receptor activation suppresses NF-kB signaling and the associated production of pro-inflammatory cytokines and ROS [4]. By reducing the oxidative and inflammatory burden on healthy cells, PDRN decreases the likelihood of stress-induced premature senescence in the remaining functional fibroblast population [4][5].
Supporting DNA Repair
PDRN provides nucleotide substrates through the salvage pathway that support base excision repair of oxidative DNA lesions [4][5]. More efficient DNA repair means fewer cells reaching the damage threshold that triggers irreversible senescence.
Counteracting SASP Effects
While PDRN cannot silence the SASP directly, its anti-inflammatory action through A2A receptor signaling counteracts many SASP components [4]. By suppressing the same cytokines (IL-6, TNF-alpha) that SASP-secreting cells produce, PDRN reduces the paracrine spread of senescence and protects healthy neighboring cells from bystander damage.
Stimulating Remaining Functional Cells
PDRN stimulates proliferation and biosynthetic activity in fibroblasts that have not yet entered senescence [4][5]. By enhancing collagen synthesis and growth factor production in the remaining healthy cell population, PDRN compensates for the functional deficit created by accumulated senescent cells.
Clinical Significance
Understanding cellular senescence explains several clinical observations about PDRN therapy [4][5]:
- Progressive improvement β PDRN's benefits accumulate over multiple sessions because it takes time to shift the balance between functional and senescent fibroblast populations
- Better outcomes in earlier intervention β Skin with fewer senescent cells has more functional fibroblasts for PDRN to stimulate, supporting earlier treatment initiation
- Synergy with antioxidants β Combining PDRN with topical antioxidants provides dual protection: antioxidants prevent oxidative senescence triggers while PDRN repairs DNA damage and supplies regenerative substrates
References
- [1]Campisi J, d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol. 2007;8(9):729-740. doi:10.1038/nrm2233
- [2]Wlaschek M, Maity P, Makrantonaki E, Scharffetter-Kochanek K. Connective tissue and fibroblast senescence in skin aging. J Invest Dermatol. 2021;141(4S):985-992. doi:10.1016/j.jid.2020.11.010
- [3]Coppe JP, Desprez PY, Krtolica A, Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol. 2010;5:99-118. doi:10.1146/annurev-pathol-121808-102144
- [4]Squadrito F, Bitto A, Irrera N, et al.. Pharmacological Activity and Clinical Use of PDRN. Curr Pharm Des. 2017;23(27):3948-3957. doi:10.2174/1381612823666170516153716
- [5]Colangelo MT, Galli C, Gentile P. Polydeoxyribonucleotide: A Promising Biological Platform for Dermal Regeneration. Curr Pharm Des. 2020;26(17):2049-2056.